About Us
Overview
Leadership Team
Milestones
Science & Pipeline
RNAi Mechanism
RNAi Therapeutics
Pipeline
Investors & Partners
Investors
Partners
Careers
Who Are We
Our Culture
Job Opportunities
News
Press Releases
Contact Us
CN
EN
About Us
Overview
Leadership Team
Milestones
Science & Pipeline
RNAi Mechanism
RNAi Therapeutics
Pipeline
Investors & Partners
Investors
Partners
Careers
Who Are We
Our Culture
Job Opportunities
News
Press Releases
Contact Us
CN
EN
News
Explore and Witness SanegeneBio' s Innovative Footprints
Press Releases
Press Releases
2024
2023
2022
2021
May 19, 2023
Dr. Weimin Wang, President of Sanegene Bio, was awarded "Sci-tech Entrepreneur of 36kr"
More
Jan. 06, 2023
SanegeneBio and Orbit Discovery Collaborate to Identify Targeting Peptides for RNAi Drugs
More
Prev
1
2
Next
Prev
2/2
Next
About Us
Overview
Leadership Team
Milestones
Science & Pipeline
RNAi Mechanism
RNAi Therapeutics
Pipeline
Careers
Who Are We
Our Culture
Job Opportunities
News
Press Releases
Contact Us
Terms of use
|
Privacy Policy
Copyright © 2024 Suzhou Sanegene Bio Inc. All rights reserved
Home
Phone
Top